Neurodegenerative Diseases: all 436 studies
Page 4 of 5. Open to participants first (143), then studies with results posted, then the rest; newest registration first within each.
- The Fixation StudyStatus unknownNCT04300777
- Community-based Cohort of Functional Decline in Subjective Cognitive Complaint ElderlyStatus unknownNCT04265482
- Pilot Study About Extra Virgin Olive Oil "Coratina" in Mild Cognitive Impairment and Alzheimer's Disease PatientsStatus unknownNCT04229186Not applicable
- Long-Term Follow-up Safety After DDS Implantation With/Without CDNF InfusionsStatus unknownNCT04228653Phase 1/2
- A First-in-Human Study of Single and Multiple Doses of anle138b in Healthy SubjectsCompletedNCT04208152Phase 1
- Focused Ultrasound and Exosomes to Treat Depression, Anxiety, and DementiasSuspendedNCT04202770Not applicable
- A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A MutationCompletedNCT04201418
- The Dutch Parkinson and Cognition StudyStatus unknownNCT04180865
- Database of Positon Emission Tomography (PET) Digital Brain Exams, in 50th Age of PatientsCompletedNCT04163276
- Non-Pharmacological Treatments and Cognitive Impairment (NPT-CI2019)Status unknownNCT04118686Not applicable
- Transcranial Magnetic Stimulation (TMS) in Multiple SclerosisStatus unknownNCT04062331Phase 1/2
- Citicoline Concentration in Human VitreousCompletedNCT04003090Not applicable
- Ccf mtDNA as a Neurodegenerative BiomarkerStatus unknownNCT03938909
- CNS Tau Kinetics in Healthy Aging and Alzheimer's DiseaseCompletedNCT03938870
- Effects of a High-intensity Progressive-cycle Program on Quality of Life and Motor Symptomatology in Parkinson's DiseaseCompletedNCT03882398Not applicable
- Mindfulness for Alzheimer CaregiversTerminatedNCT03858283Not applicable
- Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147CompletedNCT03838185Phase 1
- Imaging of Brain Structural/Functional Connectivity and Amyloid and Tau Lesions in APOE4 Carriers.WithdrawnNCT03816228
- NAD-supplementation in Drug naïve Parkinson's DiseaseCompletedNCT03816020Not applicable
- Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALSCompletedNCT03792490Phase 2
- EAP_GS010_single PatientNo longer availableNCT03672968
- Cerebrovascular Reactivity in Alzheimer's DiseaseCompletedNCT03650816
- A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831CompletedNCT03538522Phase 2
- Exploration of the Enteric Nervous System in Alzheimer DiseaseWithdrawnNCT03472183Not applicable
- Combined Stimulation of STN and SNr for Dysphagia in Parkinson's DiseaseStatus unknownNCT03470324Not applicable
- Contribution of the Therapies of Resolution of Problem in the Care of the Natural Caregivers of Patients Affected by Neurodegenerative Disease Living at HomeWithdrawnNCT03438513
- Performance Assessment Of The PMD-200 In Subjects With Degenerative Lumbar Spine Disease Who Requires Surgical ProcedureTerminatedNCT03389048Not applicable
- Supporting Elderly People With Cognitive Impairment During and After Hospital Stays- Intersectoral Care ManagementCompletedNCT03359408Not applicable
- Striatal Dopamine Transmission in Individuals With Isolated Rapid Eye Movement Sleep With Atonia: a Search for Precursor Biomarker for NeurodegenerationCompletedNCT03353207
- Evaluation of the Organization of Continuity of Care for Home Hospice Patients by Four Parisian Health NetworksCompletedNCT03336489
- Safety, Tolerability, and Pharmacokinetics Study of NDX-1017CompletedNCT03298672Phase 1
- Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's DiseaseCompletedNCT03295786Phase 1/2
- REALITY LHON RegistryCompletedNCT03295071
- Pilates as an Adjuvant Therapy in Parkinson Disease.CompletedNCT03294031Not applicable
- Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in HumansCompletedNCT03287765
- F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & UninfectedCompletedNCT03279523
- A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps.TerminatedNCT03254199Phase 2
- Behavior and Activity Monitoring in MSCompletedNCT03244696Not applicable
- The Moli-sani StudyCompletedNCT03242109
- Safety/Efficacy Study of 2nd Cycle Treatment After 6 Months of 1st Cycle HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in ALSStatus unknownNCT03214146Phase 1
- A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.TerminatedNCT03196375Phase 2
- Transcranial Magnetic Stimulation in Nonfluent/Agrammatic Variant Primary Progressive AphasiaTerminatedNCT03153540Not applicable
- Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's DiseaseCompletedNCT03065192Phase 1
- Single-Level TLIF: Post-Fusion RehabilitationCompletedNCT03033212Not applicable
- Coordination Training With Complete Body Video Games in Children and Adults With Degenerative AtaxiasCompletedNCT02874911Not applicable
- Slowing Down Disease Progression in Premanifest SCA: a Piloting Interventional Exergame TrialStatus unknownNCT02867969Not applicable
- COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICECompletedNCT02860338
- Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIMTerminatedNCT02823158Not applicable
- A Multicenter Prospective Registry for the Management of Degenerative Spine DisordersTerminatedNCT02802033
- Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic InflammationCompletedNCT02794857Phase 2
- F 18 T807 Tau PET Imaging of Frontotemporal Dementia (FTD)WithdrawnNCT02707978Phase 2
- Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)Active, not recruitingNCT02696603Not applicable
- [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative DiseaseCompletedNCT02656498Phase 2
- Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNSCompletedNCT02452216Early Phase 1
- F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E)CompletedNCT02414282
- F 18 T807 Tau PET Imaging in Familial Amyotrophic Lateral SclerosisCompletedNCT02414230
- Resveratrol and Huntington DiseaseCompletedNCT02336633Not applicable
- Pharmacologically Active Constituents of Chocolate and Their Symptomatic Effects in Patients With Idiopathic Parkinson's DiseaseStatus unknownNCT02275884Not applicable
- Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSACompletedNCT02270489Phase 1
- Study Assessing Tolerability and Safety of AFFITOPE® PD03A in Patients With Early Parkinson's DiseaseCompletedNCT02267434Phase 1
- Combination Therapy of Cord Blood and G-CSF for Patients With Brain Injury or Neurodegenerative DisordersCompletedNCT02236065Not applicable
- Quantification of Transition MetalsStatus unknownNCT02222779
- Promoting Informed Decision Making Through Advance Care PlanningStatus unknownNCT02211287Not applicable
- Olfactory Neuroepithelial Tissue of Alzheimer DiseaseCompletedNCT02129452
- Yogic Breathing Changes Salivary ComponentsCompletedNCT02108769Not applicable
- Reproducibility of the 11C-PBR28 PET SignalWithdrawnNCT02086240Not applicable
- Long-term Follow-up of Sanfilippo Type A Patients Treated by Intracerebral SAF-301 Gene TherapyCompletedNCT02053064Phase 1/2
- Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006TerminatedNCT02008513Phase 2
- NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome SequencingCompletedNCT01969370Not applicable
- Establishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative DiseasesWithdrawnNCT01954875
- Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary ConditionsCompletedNCT01953523Not applicable
- A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's DiseaseCompletedNCT01928420Phase 2
- Resource Use and Disease Course in Dementia (REDIC)CompletedNCT01920100
- Phase 2A Study of GM 608 in Mild to Moderate Parkinson DiseaseCompletedNCT01850381Phase 2
- Early Diagnosis of Alzheimer-like Dementia: Benefit of MRI and PET ImagingTerminatedNCT01815112Not applicable
- Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral SclerosisCompletedNCT01758510Phase 1
- Fox Investigation for New Discovery of BiomarkersCompletedNCT01705327
- The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-ADStatus unknownNCT01696591
- Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's DiseaseCompletedNCT01689246Phase 3
- Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's DiseaseCompletedNCT01689233Phase 3
- Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's DiseaseCompletedNCT01662414Phase 4
- Effect of Nicotinamide in Friedreich's AtaxiaStatus unknownNCT01589809Phase 2
- Oculomotor Testing in the Differential Diagnosis of DementiaCompletedNCT01577394Phase 3
- Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's DiseaseCompletedNCT01539031Phase 3
- Muscle Training of Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01504009Not applicable
- A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) BiomarkersCompletedNCT01495390
- A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington DiseaseCompletedNCT01485965Phase 1
- An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196CompletedNCT01485952Phase 1
- Intracerebral Gene Therapy for Sanfilippo Type A SyndromeCompletedNCT01474343Phase 1/2
- Health Technology Assessment of Diagnostic Approaches in Alzheimer's DiseaseCompletedNCT01450891
- A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's DiseaseCompletedNCT01404169Phase 3
- Observational Study of the Prevalence of CCSVI in Multiple Sclerosis and in Other Neurodegenerative DiseasesCompletedNCT01384825
- Electronic Nose for Diagnosis of Neurodegenerative Diseases Via Breath SamplesStatus unknownNCT01291550
- Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype CorrelationCompletedNCT01272687
- Multi-center Registry for CCSVI Testing and TreatmentSuspendedNCT01205633
- Caffeine for Motor Manifestations of Parkinson's DiseaseCompletedNCT01190735Phase 2
- Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease ProgressionCompletedNCT01141023Phase 2
- Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer PatientsCompletedNCT01097096Phase 2
- A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's DiseaseWithdrawnNCT01066481Phase 2
- Continuous Intrathecal Baclofen Infusion for Chronic SpasticityWithdrawnNCT01051128Phase 3